Gender | Current age (years) | Diagnosis | Age at diagnosis/enrolment (years) | Cause of diagnosis/enrolment | Allele 1 | Allele 2 | SCL* (mmol/L) | Current FEV1 (%) | Pancreatic status | CFTR gating (%) | Other |
---|---|---|---|---|---|---|---|---|---|---|---|
M | 36 | CF | 19 | Hypochloremic alkalosis | p.[Arg74Trp;Val201Met;Asp1270Asn] | p.Phe508del | 89 | 104 | PS | n.a. | CBAVD |
F | 58 | CF | 53 | Familiarity | p.[Arg74Trp;Val201Met;Asp1270Asn] | p.Phe508del | 62 | 105 | PS | 12.0 | |
F | 21 | CF | 9 | Familiarity | p.[Arg74Trp;Val201Met;Asp1270Asn] | p.Asn1303Lys | 109 | 119 | PS | 9.8 | IGT |
F | 23 | CF | 10 | Respiratory | p.[Arg74Trp;Val201Met;Asp1270Asn] | p.Asn1303Lys | 65 | 95 | PS | 11.8 | IGT; bronchiectasis |
M | 12 | CFTR-RD | 6 | Respiratory | p.[Arg74Trp;Val201Met;Asp1270Asn] | p.Phe508del | 37 | 87 | PS | 15.0 | |
M | 13 | CFTR-RD | 1 | Hypochloremic alkalosis | p.[Arg74Trp;Val201Met;Asp1270Asn] | p.Ser1206* | 46 | 91 | PS | n.a. | |
M | 37 | CFTR-RD | 32 | CBAVD | p.[Arg74Trp;Val201Met;Asp1270Asn] | p.Asp579Gly | 118 | 99 | PS | 19.1 | |
M | 48 | CFTR-RD | 42 | CBAVD | p.[Arg74Trp;Val201Met;Asp1270Asn] | p.Asp1152His | 31 | n.a. | PS | 18.5 | |
M | 40 | CFTR-RD | 34 | CBAVD | p.[Arg74Trp;Asp1270Asn] | c.[1210-34TG[12];1210-12T[5]] | 32 | n.a. | PS | 18.9 | |
F | 5 | Healthy | 1 | NBS | p.[Arg74Trp;Asp1270Asn] | p.Phe508del | 11 | n.a. | PS | n.a. | |
M | 40 | Healthy | 35 | Familiarity | p.Asp1270Asn | p.Asn1303Lys | 9 | n.a. | PS | n.a. | |
M | 40 | Healthy | 35 | Familiarity | p.Asp1270Asn | p.Phe508del | 12 | n.a. | PS | 44.0 | |
M | 50 | Healthy | 40 | Familiarity | p.[Arg74Trp;Asp1270Asn] | N | n.a. | n.a. | n.a. | 92.6 | |
F | 47 | Healthy | 47 | Familiarity | p.[Arg74Trp;Asp1270Asn] | N | n.a. | n.a. | n.a. | 94.0 |
*For patients with CF, we reported SCL at diagnosis while for CFTR-RD and for healthy subjects we reported current SCL; values in italics represent SCL discordant with diagnosis.
CBAVD, congenital bilateral absence of vas deferens; CF, cystic fibrosis; CFTR-RD, cystic fibrosis transmembrane conductance regulator -related disorders; FEV1, forced expiratory volume in 1 second; IGT, impaired glucose tolerance; n.a., not assessed; N, wild-type allele; NBS, newborn screening; PS, pancreatic sufficiency; SCL, sweat chloride level.